SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-375650
Filing Date
2015-11-12
Accepted
2015-11-12 16:09:29
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d14800d10q.htm 10-Q 516377
2 EX-10.1 d14800dex101.htm EX-10.1 119976
3 EX-10.2 d14800dex102.htm EX-10.2 359563
4 EX-31.1 d14800dex311.htm EX-31.1 8213
5 EX-31.2 d14800dex312.htm EX-31.2 8198
6 EX-32.1 d14800dex321.htm EX-32.1 4243
  Complete submission text file 0001193125-15-375650.txt   3425249

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cbay-20150930.xml EX-101.INS 469234
8 XBRL TAXONOMY EXTENSION SCHEMA cbay-20150930.xsd EX-101.SCH 37782
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20150930_cal.xml EX-101.CAL 54330
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20150930_def.xml EX-101.DEF 98866
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20150930_lab.xml EX-101.LAB 306343
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20150930_pre.xml EX-101.PRE 204647
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 151224894
SIC: 2834 Pharmaceutical Preparations